PDB Short entry for 5VKJ HEADER IMMUNE SYSTEM 21-APR-17 5VKJ TITLE CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-CELL RECEPTOR CD22; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN RESIDUES 20-330; COMPND 5 SYNONYM: B-LYMPHOCYTE CELL ADHESION MOLECULE,BL-CAM,SIALIC ACID- COMPND 6 BINDING IG-LIKE LECTIN 2,SIGLEC-2,T-CELL SURFACE ANTIGEN LEU-14; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD22, SIGLEC2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS SIGLEC, SIALIC ACID, CARBOHYDRATE BINDING PROTEIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.P.JULIEN,J.ERENO-ORBEA,T.SICARD REVDAT 6 03-APR-24 5VKJ 1 HETSYN LINK REVDAT 5 29-JUL-20 5VKJ 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 27-NOV-19 5VKJ 1 REMARK REVDAT 3 20-NOV-19 5VKJ 1 REMARK REVDAT 2 25-OCT-17 5VKJ 1 JRNL REVDAT 1 04-OCT-17 5VKJ 0 JRNL AUTH J.ERENO-ORBEA,T.SICARD,H.CUI,M.T.MAZHAB-JAFARI,S.BENLEKBIR, JRNL AUTH 2 A.GUARNE,J.L.RUBINSTEIN,J.P.JULIEN JRNL TITL MOLECULAR BASIS OF HUMAN CD22 FUNCTION AND THERAPEUTIC JRNL TITL 2 TARGETING. JRNL REF NAT COMMUN V. 8 764 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 28970495 JRNL DOI 10.1038/S41467-017-00836-6 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 18725 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.2528 - 4.0546 1.00 2595 142 0.1699 0.1762 REMARK 3 2 4.0546 - 3.2185 1.00 2560 132 0.1774 0.2238 REMARK 3 3 3.2185 - 2.8118 1.00 2534 130 0.2147 0.2517 REMARK 3 4 2.8118 - 2.5547 1.00 2524 138 0.2263 0.2678 REMARK 3 5 2.5547 - 2.3716 1.00 2523 134 0.2529 0.3178 REMARK 3 6 2.3716 - 2.2318 1.00 2522 132 0.2652 0.3009 REMARK 3 7 2.2318 - 2.1200 1.00 2527 132 0.2827 0.3340 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2624 REMARK 3 ANGLE : 0.537 3566 REMARK 3 CHIRALITY : 0.041 409 REMARK 3 PLANARITY : 0.003 444 REMARK 3 DIHEDRAL : 11.655 1590 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VKJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227573. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18725 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 46.242 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.45710 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: CRYSTAL STRUCTURE FROM A DIFFERENT CRYSTAL REMARK 200 OBTAINED WITH THIS CONSTRUCT BY MAD PHASING WITH HEAVY ATOM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.2 M LITHIUM CHLORIDE REMARK 280 AND 0.1 M TRIS PH 8.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 63.40350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.28450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 63.40350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.28450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER AS DETERMINED BY GEL FILTRATION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 514 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 625 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 329 REMARK 465 ALA A 330 REMARK 465 GLY A 331 REMARK 465 GLY A 332 REMARK 465 THR A 333 REMARK 465 LYS A 334 REMARK 465 HIS A 335 REMARK 465 HIS A 336 REMARK 465 HIS A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 38 -157.80 -89.24 REMARK 500 LYS A 81 -61.23 -104.99 REMARK 500 ASP A 97 -152.77 -136.63 REMARK 500 ASN A 99 -25.54 -146.10 REMARK 500 SER A 123 -155.96 -97.56 REMARK 500 SER A 166 126.25 -170.36 REMARK 500 PRO A 272 -168.10 -74.51 REMARK 500 ASN A 313 -162.78 -129.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VKM RELATED DB: PDB REMARK 900 RELATED ID: 5VKK RELATED DB: PDB REMARK 900 RELATED ID: 5VL3 RELATED DB: PDB REMARK 900 RELATED ID: EMD-8704 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-8705 RELATED DB: EMDB REMARK 900 RELATED ID: SASDC76 RELATED DB: SASBDB REMARK 900 RELATED ID: SASDC86 RELATED DB: SASBDB DBREF 5VKJ A 20 330 UNP P20273 CD22_HUMAN 20 330 SEQADV 5VKJ GLU A 17 UNP P20273 EXPRESSION TAG SEQADV 5VKJ THR A 18 UNP P20273 EXPRESSION TAG SEQADV 5VKJ GLY A 19 UNP P20273 EXPRESSION TAG SEQADV 5VKJ ALA A 67 UNP P20273 ASN 67 ENGINEERED MUTATION SEQADV 5VKJ ALA A 112 UNP P20273 ASN 112 ENGINEERED MUTATION SEQADV 5VKJ ALA A 135 UNP P20273 ASN 135 ENGINEERED MUTATION SEQADV 5VKJ ALA A 164 UNP P20273 ASN 164 ENGINEERED MUTATION SEQADV 5VKJ ALA A 231 UNP P20273 ASN 231 ENGINEERED MUTATION SEQADV 5VKJ GLY A 331 UNP P20273 EXPRESSION TAG SEQADV 5VKJ GLY A 332 UNP P20273 EXPRESSION TAG SEQADV 5VKJ THR A 333 UNP P20273 EXPRESSION TAG SEQADV 5VKJ LYS A 334 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 335 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 336 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 337 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 338 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 339 UNP P20273 EXPRESSION TAG SEQADV 5VKJ HIS A 340 UNP P20273 EXPRESSION TAG SEQRES 1 A 324 GLU THR GLY ASP SER SER LYS TRP VAL PHE GLU HIS PRO SEQRES 2 A 324 GLU THR LEU TYR ALA TRP GLU GLY ALA CYS VAL TRP ILE SEQRES 3 A 324 PRO CYS THR TYR ARG ALA LEU ASP GLY ASP LEU GLU SER SEQRES 4 A 324 PHE ILE LEU PHE HIS ASN PRO GLU TYR ASN LYS ALA THR SEQRES 5 A 324 SER LYS PHE ASP GLY THR ARG LEU TYR GLU SER THR LYS SEQRES 6 A 324 ASP GLY LYS VAL PRO SER GLU GLN LYS ARG VAL GLN PHE SEQRES 7 A 324 LEU GLY ASP LYS ASN LYS ASN CYS THR LEU SER ILE HIS SEQRES 8 A 324 PRO VAL HIS LEU ALA ASP SER GLY GLN LEU GLY LEU ARG SEQRES 9 A 324 MET GLU SER LYS THR GLU LYS TRP MET GLU ARG ILE HIS SEQRES 10 A 324 LEU ALA VAL SER GLU ARG PRO PHE PRO PRO HIS ILE GLN SEQRES 11 A 324 LEU PRO PRO GLU ILE GLN GLU SER GLN GLU VAL THR LEU SEQRES 12 A 324 THR CYS LEU LEU ALA PHE SER CYS TYR GLY TYR PRO ILE SEQRES 13 A 324 GLN LEU GLN TRP LEU LEU GLU GLY VAL PRO MET ARG GLN SEQRES 14 A 324 ALA ALA VAL THR SER THR SER LEU THR ILE LYS SER VAL SEQRES 15 A 324 PHE THR ARG SER GLU LEU LYS PHE SER PRO GLN TRP SER SEQRES 16 A 324 HIS HIS GLY LYS ILE VAL THR CYS GLN LEU GLN ASP ALA SEQRES 17 A 324 ASP GLY LYS PHE LEU SER ALA ASP THR VAL GLN LEU ASN SEQRES 18 A 324 VAL LYS HIS THR PRO LYS LEU GLU ILE LYS VAL THR PRO SEQRES 19 A 324 SER ASP ALA ILE VAL ARG GLU GLY ASP SER VAL THR MET SEQRES 20 A 324 THR CYS GLU VAL SER SER SER ASN PRO GLU TYR THR THR SEQRES 21 A 324 VAL SER TRP LEU LYS ASP GLY THR SER LEU LYS LYS GLN SEQRES 22 A 324 ASN THR PHE THR LEU ASN LEU ARG GLU VAL THR LYS ASP SEQRES 23 A 324 GLN SER GLY LYS TYR CYS CYS GLN VAL SER ASN ASP VAL SEQRES 24 A 324 GLY PRO GLY ARG SER GLU GLU VAL PHE LEU GLN VAL GLN SEQRES 25 A 324 TYR ALA GLY GLY THR LYS HIS HIS HIS HIS HIS HIS HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET MAN B 5 11 HET GOL A 406 6 HET GOL A 407 6 HET GOL A 408 6 HET GOL A 409 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN 2(C6 H12 O6) FORMUL 3 GOL 4(C3 H8 O3) FORMUL 7 HOH *162(H2 O) HELIX 1 AA1 ASP A 20 SER A 22 5 3 HELIX 2 AA2 LYS A 81 VAL A 85 5 5 HELIX 3 AA3 HIS A 110 SER A 114 5 5 HELIX 4 AA4 GLN A 209 HIS A 213 5 5 HELIX 5 AA5 THR A 300 SER A 304 5 5 SHEET 1 AA1 2 TRP A 24 GLU A 27 0 SHEET 2 AA1 2 THR A 45 ALA A 48 -1 O THR A 45 N GLU A 27 SHEET 1 AA2 5 THR A 31 TRP A 35 0 SHEET 2 AA2 5 LYS A 127 SER A 137 1 O ALA A 135 N LEU A 32 SHEET 3 AA2 5 GLY A 115 GLU A 122 -1 N LEU A 117 O ILE A 132 SHEET 4 AA2 5 SER A 55 ASN A 65 -1 N PHE A 59 O GLY A 118 SHEET 5 AA2 5 LYS A 70 GLU A 78 -1 O LYS A 70 N ASN A 65 SHEET 1 AA3 3 VAL A 40 ILE A 42 0 SHEET 2 AA3 3 LEU A 104 ILE A 106 -1 O LEU A 104 N ILE A 42 SHEET 3 AA3 3 VAL A 92 PHE A 94 -1 N GLN A 93 O SER A 105 SHEET 1 AA4 4 HIS A 144 GLN A 146 0 SHEET 2 AA4 4 VAL A 157 LEU A 163 -1 O THR A 160 N GLN A 146 SHEET 3 AA4 4 VAL A 198 PHE A 206 -1 O PHE A 206 N VAL A 157 SHEET 4 AA4 4 ALA A 187 LEU A 193 -1 N SER A 190 O ARG A 201 SHEET 1 AA5 4 VAL A 181 PRO A 182 0 SHEET 2 AA5 4 ILE A 172 LEU A 178 -1 N LEU A 178 O VAL A 181 SHEET 3 AA5 4 ILE A 216 ASP A 223 -1 O THR A 218 N LEU A 177 SHEET 4 AA5 4 PHE A 228 GLN A 235 -1 O SER A 230 N LEU A 221 SHEET 1 AA6 3 HIS A 240 THR A 249 0 SHEET 2 AA6 3 VAL A 261 ASN A 271 -1 O GLU A 266 N GLU A 245 SHEET 3 AA6 3 THR A 293 LEU A 296 -1 O LEU A 294 N MET A 263 SHEET 1 AA7 5 ILE A 254 VAL A 255 0 SHEET 2 AA7 5 VAL A 323 VAL A 327 1 O GLN A 326 N VAL A 255 SHEET 3 AA7 5 GLY A 305 SER A 312 -1 N TYR A 307 O VAL A 323 SHEET 4 AA7 5 THR A 276 LYS A 281 -1 N LEU A 280 O CYS A 308 SHEET 5 AA7 5 THR A 284 LEU A 286 -1 O LEU A 286 N TRP A 279 SHEET 1 AA8 4 ILE A 254 VAL A 255 0 SHEET 2 AA8 4 VAL A 323 VAL A 327 1 O GLN A 326 N VAL A 255 SHEET 3 AA8 4 GLY A 305 SER A 312 -1 N TYR A 307 O VAL A 323 SHEET 4 AA8 4 PRO A 317 ARG A 319 -1 O GLY A 318 N VAL A 311 SSBOND 1 CYS A 39 CYS A 167 1555 1555 2.04 SSBOND 2 CYS A 44 CYS A 102 1555 1555 2.03 SSBOND 3 CYS A 161 CYS A 219 1555 1555 2.03 SSBOND 4 CYS A 265 CYS A 309 1555 1555 2.03 LINK ND2 ASN A 101 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.45 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.44 LINK O6 BMA B 3 C1 MAN B 5 1555 1555 1.45 CISPEP 1 HIS A 107 PRO A 108 0 0.48 CISPEP 2 THR A 249 PRO A 250 0 4.15 CISPEP 3 ASN A 271 PRO A 272 0 -0.39 CRYST1 126.807 56.569 49.434 90.00 110.70 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007886 0.000000 0.002980 0.00000 SCALE2 0.000000 0.017678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021625 0.00000